News Quantified

INSM – insmed incorporated (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) [Yahoo! Finance]

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed To Present at the 43rd Annual J.P. Morgan Healthcare Conference

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Non-Cystic Fibrosis Bronchiectasis Market Insight, Epidemiology and Market Forecast 2024-2034 [Yahoo! Finance]

-5.3%

MISS

5.6%

MISS

1.3%

BEAT

-3.9%

MISS

Form 144 INSMED Inc Filed by: Bonstein Sara

Form 144 INSMED Inc Filed by: Flammer Martina M.D.

Form 144 INSMED Inc Filed by: Adsett Roger

Form 144 INSMED Inc Filed by: Smith Michael Alexander

Form 144 INSMED Inc Filed by: Wise John Drayton

Top News Gainers

2/3 Insmed Announces Positive Top-Line Results from Phase 2 WILLOW Study of INS1007 in Patients with Non-Cystic Fibrosis Bronchiectasis 40.6%

2/4 Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Goldman Sachs Group Inc from $33.00 to $46.00. They now have a "buy" rating on the stock. 12.6%

3/17 Insmed Incorporated (NASDAQ: INSM) had its price target lowered by analysts at Stifel Nicolaus from $55.00 to $45.00. They now have a "buy" rating on the stock. 12.6%

4/30 Insmed Reports First Quarter 2020 Financial Results and Provides Business Update 8.0%

10/11 Insmed Incorporated (NASDAQ: INSM) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 7.9%

4/2 Insmed Appoints Carol A. Schafer to its Board of Directors 7.1%

10/30 Form 10-Q INSMED Inc For: Sep 30 6.7%

4/20 Insmed to Host First Quarter 2020 Financial Results Conference Call on Thursday, April 30, 2020 6.5%

1/7 Form 4 INSMED Inc For: Jan 03 Filed by: SORIANO JOHN 6.1%

6/12 Form 3 INSMED Inc For: Jun 03 Filed by: GOLL JOHN 5.7%

Top News Decliners

2/25 Q4/2019 12/31/2019 EPS -0.590 ZacksConsensus -0.590 ActVsEst 0.000 - In-Line -16.4%

5/7 Q1/2019 3/31/2019 EPS -0.960 ZacksConsensus -0.940 ActVsEst (0.020) - Miss -13.0%

8/1 Q2/2019 6/30/2019 EPS -0.810 ZacksConsensus -0.850 ActVsEst 0.040 - Beat -12.3%

2/26 Galapagos Ratings Downgrade, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha] -8.1%

3/31 Form DEFA14A INSMED Inc -6.6%

8/2 Insmed, Inc. (INSM) CEO Will Lewis on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -6.1%

5/20 New Phase 3 Data Show Sustainability and Durability of Culture Conversion with ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with Refractory MAC Lung Disease -5.9%

3/7 Insmed Incorporated (NASDAQ: INSM) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -5.9%

3/5 Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) -5.7%

1/16 Insmed Incorporated (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at JMP Securities. They now have a $40.00 price target on the stock. -5.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day